Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Agomelatine reversal of escitalopram-induced apathy: a case report.

De Berardis D, Valchera A, Fornaro M, Serroni N, Marini S, Moschetta FS, Martinotti G, Di Giannantonio M.

Psychiatry Clin Neurosci. 2013 Apr;67(3):190-1. doi: 10.1111/pcn.12032. No abstract available.

2.

Efficacy of agomelatine and escitalopram on depression, subjective sleep and emotional experiences in patients with major depressive disorder: a 24-wk randomized, controlled, double-blind trial.

Corruble E, de Bodinat C, Belaïdi C, Goodwin GM; agomelatine study group.

Int J Neuropsychopharmacol. 2013 Nov;16(10):2219-34. doi: 10.1017/S1461145713000679. Epub 2013 Jul 3.

PMID:
23823799
3.

Comparison of agomelatine and escitalopram on nighttime sleep and daytime condition and efficacy in major depressive disorder patients.

Quera-Salva MA, Hajak G, Philip P, Montplaisir J, Keufer-Le Gall S, Laredo J, Guilleminault C.

Int Clin Psychopharmacol. 2011 Sep;26(5):252-62. doi: 10.1097/YIC.0b013e328349b117.

PMID:
21829106
4.

A pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertraline.

Demyttenaere K, Corruble E, Hale A, Quera-Salva MA, Picarel-Blanchot F, Kasper S.

CNS Spectr. 2013 Jun;18(3):163-70. doi: 10.1017/S1092852913000060. Epub 2013 Mar 11.

PMID:
23472671
5.

A case of hyponatremia associated with escitalopram.

Nahshoni E, Weizman A, Shefet D, Pik N.

J Clin Psychiatry. 2004 Dec;65(12):1722. No abstract available.

PMID:
15641882
6.

Hypomania induced by escitalopram: 2 case reports.

Sharma RC.

Psychopharmacol Bull. 2009;42(2):89-91.

PMID:
19629025
7.

Delirium during i. v. citalopram treatment: a case report.

Delić M, Pregelj P.

Pharmacopsychiatry. 2013 Jan;46(1):37-8. doi: 10.1055/s-0032-1316383. Epub 2012 Jul 20.

PMID:
22821385
8.

Citalopram-induced major depression in a patient with panic disorder - a case report.

Hofmann P, Conrad R.

Psychiatr Danub. 2012 Mar;24(1):94-6. No abstract available.

9.

Apathy in currently nondepressed patients treated with a SSRI for a major depressive episode: outcomes following randomized switch to either duloxetine or escitalopram.

Raskin J, George T, Granger RE, Hussain N, Zhao GW, Marangell LB.

J Psychiatr Res. 2012 May;46(5):667-74. doi: 10.1016/j.jpsychires.2012.02.010. Epub 2012 Mar 10.

PMID:
22410206
10.

The safety of the electroconvulsive therapy-escitalopram combination.

Masdrakis VG, Oulis P, Florakis A, Valamoutopoulos T, Markatou M, Papadimitriou GN.

J ECT. 2008 Dec;24(4):289-91. doi: 10.1097/YCT.0b013e31816ba99d.

PMID:
18617866
11.

A case of obsessive-compulsive disorder successfully treated with agomelatine monotherapy.

De Berardis D, Serroni N, Campanella D, Olivieri L, Moschetta FS, Conti CM, Conti P, Di Giannantonio M.

J Clin Psychopharmacol. 2012 Apr;32(2):289-90. doi: 10.1097/JCP.0b013e318249298c. No abstract available.

PMID:
22388158
12.

Bilateral ankle oedema in a patient taking escitalopram.

Masdrakis VG, Oulis P, Kouzoupis AV, Masdrakis GV, Soldatos CR.

World J Biol Psychiatry. 2009;10(4 Pt 3):939-41.

PMID:
17853268
13.

Cost-effectiveness of escitalopram in major depressive disorder in the Dutch health care setting.

Nuijten MJ, Brignone M, Marteau F, den Boer JA, Hoencamp E.

Clin Ther. 2012 Jun;34(6):1364-78. doi: 10.1016/j.clinthera.2012.04.006. Epub 2012 May 11.

PMID:
22578310
14.

Selective serotonin reuptake inhibitors in adolescent depression still controversial.

Holzer L, Baumann P.

J Clin Psychopharmacol. 2007 Jun;27(3):325-6; author reply 326. No abstract available.

PMID:
17502798
15.

[Agomelatine].

Tessmer M.

Med Monatsschr Pharm. 2009 Aug;32(8):282-8. Review. German.

PMID:
19777735
16.

Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.

Lam RW, Lönn SL, Despiégel N.

Int Clin Psychopharmacol. 2010 Jul;25(4):199-203. doi: 10.1097/YIC.0b013e32833948d8.

PMID:
20357664
17.

Antidepressant efficacy of agomelatine versus SSRI/SNRI: results from a pooled analysis of head-to-head studies without a placebo control.

Kasper S, Corruble E, Hale A, Lemoine P, Montgomery SA, Quera-Salva MA.

Int Clin Psychopharmacol. 2013 Jan;28(1):12-9. doi: 10.1097/YIC.0b013e328359768e.

PMID:
23023074
18.

Cost effectiveness of escitalopram versus SNRIs in second-step treatment of major depressive disorder in Sweden.

Nordström G, Despiegel N, Marteau F, Danchenko N, Maman K.

J Med Econ. 2010;13(3):516-26. doi: 10.3111/13696998.2010.506371.

PMID:
20698748
19.

Venous thromboembolism and escitalopram.

Kurne A, Ertugrul A, Anil Yağcioğlu AE, Yazici KM.

Gen Hosp Psychiatry. 2004 Nov-Dec;26(6):481-3.

PMID:
15567215
20.

Treatment with citalopram, but not with agomelatine, adversely affects sperm parameters: a case report and translational review.

Elnazer HY, Baldwin DS.

Acta Neuropsychiatr. 2014 Apr;26(2):125-9. doi: 10.1017/neu.2013.60.

PMID:
24855891

Supplemental Content

Support Center